PAX.ST
Healthcare Medical DevicesPaxman AB (publ)
SEK 66.20
-0.50 -0.75% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 7, 2026, live at 11:17 AM ET | 66.20 |
Key Stats
Market Cap
1.54B
Avg Volume
27,776
EPS
-SEK 0.22
52W High
SEK 70.20
52W Low
SEK 41.00
Div. Yield
0.0%
Valuation
Forward P/E
16.15
P/B Ratio
3.70
P/S Ratio
4.21
EV/EBITDA
38.90
EV/Revenue
3.99
Margins
Gross Margin 64.1%
Operating Margin 3.7%
Net Margin (1.5%)
EBITDA Margin 10.3%
Growth & Returns
Revenue Growth (YoY)
40.3%
Return on Equity
(1.3%)
Return on Assets
0.2%
Liquidity & Leverage
Current Ratio
4.45
Quick Ratio
3.75
Debt / Equity
0.03
Total Cash
105.64M
Total Debt
12.37M
About
Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Karlshamn, Sweden.
paxmanscalpcooling.com